(Q35841706)

10 August 2017

1 reference

title

Alzheimer's disease is a vasocognopathy: a new term to describe its nature (English)

1 reference

10 August 2017

0 references

Jack C de la Torre

1

1 reference

10 August 2017

1 July 2004

1 reference

10 August 2017

Neurological Research

1 reference

10 August 2017

26

1 reference

10 August 2017

5

1 reference

10 August 2017

517-524

1 reference

Impaired brain microcirculation may trigger Alzheimer's disease

10 August 2017

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Critical threshold cerebral hypoperfusion causes Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Alzheimer disease as a vascular disorder: nosological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

The role of cerebral ischemia in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Small vessel disease and Alzheimer's dementia: pathological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Silent brain infarcts and the risk of dementia and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Head injury and the risk of AD in the MIRAGE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Microemboli in cerebral circulation and alteration of cognitive abilities in patients with mechanical prosthetic heart valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Nitric oxide and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Vascular disease and cognitive function in older men in the Caerphilly cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

21 January 2018

The nosology of dementia

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Perfusion abnormalities in prodromal AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Hippocampal perfusion in mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

A novel treatment for patients with Alzheimer's disease and with vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Differences in executive functioning between Alzheimer's disease and subcortical ischemic vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Pharmacotherapy for Alzheimer's disease: 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Effect of acute administration of L-acetyl carnitine on cerebral blood flow in patients with chronic cerebral infarct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Vascular risk and genetics of sporadic late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Angiotensin II receptor binding sites in brain microvessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Vascular factors in cognitive impairment--where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Incidence and Risk Factors of Dementia in a Defined Elderly Japanese Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164104225016254

10.1179/016164104225016254

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15265269